AASLD Meeting

Related by string. * : Liver Diseases AASLD . Liver Disease AASLD . School Librarians AASL . AASLD . AASL / meeting . Meets . meets . meet . MEETING . MEET . MEETS . Meeter . meeter . mee ting : General Meeting . Town Meeting . Annual Shareholder Meeting . Will Meet Tall . Meeting Room . LAST MEETING . Government Meeting CHOGM . Plymouth Meeting . Swap Meet . NBC Meet . Europe Meeting ASEM . COURTESY NBC Meet * *

Related by context. Frequent words. (Click for all words.) 71 Clinical Trial Results 71 ASH Annual Meeting 68 SABCS 68 Preclinical Data 67 EORTC NCI AACR Symposium 67 Chronic Hepatitis C 66 Pivotal Phase III 66 Phase III Clinical Trial 66 Drug Candidate 66 ICAAC 66 Hematology Annual Meeting 66 Gastrointestinal Cancers Symposium 66 EORTC NCI AACR 66 Oral Presentation 65 Phase III Trial 65 CROI 65 AACR NCI EORTC 65 Patient Enrollment 65 #th Annual Interscience 64 Pivotal Phase 64 Metastatic Melanoma 63 Poster Presentation 63 Monotherapy 63 Carfilzomib 63 Completes Enrollment 62 annual Transcatheter Cardiovascular 62 Clinical Oncology Annual Meeting 62 EASL 62 Chronic Lymphocytic Leukemia 62 Pulmonary Arterial Hypertension 62 Epratuzumab 62 Presents Positive 62 Immunogenicity 62 Pirfenidone 62 Hematology ASH Annual Meeting 62 Abstract Number 61 Metastatic Colorectal Cancer 61 BIO InvestorForum 61 Annual Scientific Sessions 61 Well Tolerated 61 FDA Accepts 61 Natalizumab 61 ASCO Annual Meeting 60 Pivotal Trial 60 AASLD 60 Opportunistic Infections CROI 60 metastatic castration resistant 60 Dasatinib 59 RNAi Therapeutics 59 #st Annual Meeting 59 Gastrointestinal Cancer 59 Inc. Nasdaq IMGN 59 Solid Tumors 59 J Am Coll 59 Cancer Res 59 Combination Therapy 59 Phase Ib clinical 59 Benign Prostatic Hyperplasia 58 Announces Presentation 58 Panzem R 58 Traficet EN 58 liposomal formulation 58 PEG SN# 58 Antiviral 58 Molecular Targets 58 Annual BIO 58 Patients Treated 58 Sym# 58 J Clin Endocrinol Metab 58 RADIANT 58 Medical Oncology ESMO 58 Advanced Prostate Cancer 58 Lenalidomide 58 Overactive Bladder 58 J Clin Oncol 58 Initiates Phase 58 Transcatheter Cardiovascular Therapeutics TCT 57 Cambridge Healthtech Institute 57 Arch Neurol 57 Chemotherapy ICAAC 57 metastatic hormone refractory 57 J Natl Cancer Inst 57 Vandetanib 57 elotuzumab 57 Clin Infect Dis 57 Monoclonal Antibodies 57 Heart Failure Patients 57 Low Dose 57 Bortezomib 57 Small Molecule 57 Monoclonal Antibody 57 Gemzar ® 57 ZD# [001] 57 CCX# 57 Antimicrobial Agents 57 BAL# [001] 57 anticancer compound 57 Controlled Release 57 ARVO 57 MEK inhibitor 57 ganetespib

Back to home page